Vienna Insurance Group’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $968K | Hold |
85,000
| – | – | 0.61% | 24 |
|
|
2025
Q1 | $1.01M | Hold |
85,000
| – | – | 0.55% | 78 |
|
|
2024
Q4 | $1.6M | Hold |
85,000
| – | – | 0.93% | 20 |
|
|
2024
Q3 | $1.91M | Hold |
85,000
| – | – | 0.81% | 26 |
|
|
2024
Q2 | $1.77M | Hold |
85,000
| – | – | 0.69% | 29 |
|
|
2024
Q1 | $1.25M | Hold |
85,000
| – | – | 0.49% | 86 |
|
|
2023
Q4 | $877K | Hold |
85,000
| – | – | 0.4% | 90 |
|
|
2023
Q3 | $668K | Hold |
85,000
| – | – | 0.3% | 90 |
|
|
2023
Q2 | $849K | Hold |
85,000
| – | – | 0.39% | 87 |
|
|
2023
Q1 | $755K | Buy |
+85,000
| New | +$755K | 0.44% | 53 |
|